Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Luszczak S, Simpson BS, Stopka-Farooqui U, Sathyadevan VK, Echeverria LMC, Kumar C, Costa H, Haider A, Freeman A, Jameson C, Ratynska M, Ben-Salha I, Sridhar A, Shaw G, Kelly JD, Pye H, Gately KA, Whitaker HC, Heavey S.
Luszczak S, et al. Among authors: sridhar a.
Sci Rep. 2020 Sep 1;10(1):14380. doi: 10.1038/s41598-020-71263-9.
Sci Rep. 2020.
PMID: 32873828
Free PMC article.